Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27


Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.

Nakayama M, Itoh Y, Shichinohe S, Nakabayashi R, Ishigaki H, Sakoda Y, Le QM, Kawaoka Y, Kida H, Ogasawara K.

Vaccine. 2017 Feb 15;35(7):1008-1017. doi: 10.1016/j.vaccine.2017.01.008. Epub 2017 Jan 18.


[Sucrose reward promotes rats' motivation for cocaine].

Li YQ, LE QM, Yu XC, Ma L, Wang FF.

Sheng Li Xue Bao. 2016 Jun 25;68(3):233-40. Chinese.


Circulation of influenza B lineages in northern Viet Nam, 2007-2014.

Le TT, Pham TH, Pham TH, Nguyen le KH, Nguyen CT, Hoang VM, Tran TH, Nguyen VS, Ngo HG, Le QM.

Western Pac Surveill Response J. 2015 Nov 11;6(4):17-23. doi: 10.5365/WPSAR.2015.6.1.022. eCollection 2015 Oct-Dec.


Antibody landscapes after influenza virus infection or vaccination.

Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NMH, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WEP, Le QM, Nguyen TH, Wertheim HFL, Hurt AC, Osterhaus ADME, Barr IG, Fouchier RAM, Horby PW, Smith DJ.

Science. 2014 Nov 21;346(6212):996-1000. doi: 10.1126/science.1256427.


Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.

Kitano M, Itoh Y, Ishigaki H, Nakayama M, Ishida H, Pham VL, Arikata M, Shichinohe S, Tsuchiya H, Kitagawa N, Kobayashi M, Yoshida R, Sato A, Le QM, Kawaoka Y, Ogasawara K.

Antimicrob Agents Chemother. 2014 Aug;58(8):4795-803. doi: 10.1128/AAC.02817-14. Epub 2014 Jun 9.


Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.

Nakayama M, Shichinohe S, Itoh Y, Ishigaki H, Kitano M, Arikata M, Pham VL, Ishida H, Kitagawa N, Okamatsu M, Sakoda Y, Ichikawa T, Tsuchiya H, Nakamura S, Le QM, Ito M, Kawaoka Y, Kida H, Ogasawara K.

PLoS One. 2013 Dec 23;8(12):e82740. doi: 10.1371/journal.pone.0082740. eCollection 2013.


Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.

Hoang Vu MP, Nguyen CT, Nguyen le KH, Nguyen TK, Le QM.

Western Pac Surveill Response J. 2013 Jun 26;4(2):25-9. doi: 10.5365/WPSAR.2013.4.1.010. eCollection 2013 Apr-Jun.


Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.

Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y.

J Infect Dis. 2013 Jan 1;207(1):89-97. doi: 10.1093/infdis/jis633. Epub 2012 Oct 10.


Isolation and characterization of H6N1 and H9N2 avian influenza viruses from Ducks in Hanoi, Vietnam.

Hotta K, Takakuwa H, Le QM, Phuong SL, Murase T, Ono E, Ito T, Otsuki K, Yamashiro T.

Virus Res. 2012 Feb;163(2):448-53. doi: 10.1016/j.virusres.2011.11.004. Epub 2011 Nov 12.


Adaptation of a duck influenza A virus in quail.

Yamada S, Shinya K, Takada A, Ito T, Suzuki T, Suzuki Y, Le QM, Ebina M, Kasai N, Kida H, Horimoto T, Rivailler P, Chen LM, Donis RO, Kawaoka Y.

J Virol. 2012 Feb;86(3):1411-20. doi: 10.1128/JVI.06100-11. Epub 2011 Nov 16.


H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.

Khurana S, Sasono P, Fox A, Nguyen VK, Le QM, Pham QT, Nguyen TH, Nguyen TL, Horby P, Golding H.

J Virol. 2011 Dec;85(23):12455-63. doi: 10.1128/JVI.06023-11. Epub 2011 Sep 28.


Subclinical brain injury caused by H5N1 influenza virus infection.

Shinya K, Makino A, Hatta M, Watanabe S, Kim JH, Hatta Y, Gao P, Ozawa M, Le QM, Kawaoka Y.

J Virol. 2011 May;85(10):5202-7. doi: 10.1128/JVI.00239-11. Epub 2011 Mar 9.


Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.

Khadka DB, Le QM, Yang SH, Van HT, Le TN, Cho SH, Kwon Y, Lee KT, Lee ES, Cho WJ.

Bioorg Med Chem. 2011 Mar 15;19(6):1924-9. doi: 10.1016/j.bmc.2011.01.064. Epub 2011 Feb 3.


Social contact patterns in Vietnam and implications for the control of infectious diseases.

Horby P, Pham QT, Hens N, Nguyen TT, Le QM, Dang DT, Nguyen ML, Nguyen TH, Alexander N, Edmunds WJ, Tran ND, Fox A, Nguyen TH.

PLoS One. 2011 Feb 14;6(2):e16965. doi: 10.1371/journal.pone.0016965.


Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam.

Le QM, Ito M, Muramoto Y, Hoang PV, Vuong CD, Sakai-Tagawa Y, Kiso M, Ozawa M, Takano R, Kawaoka Y.

J Gen Virol. 2010 Oct;91(Pt 10):2485-90. doi: 10.1099/vir.0.021659-0. Epub 2010 Jun 30.


Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.

Kiso M, Kubo S, Ozawa M, Le QM, Nidom CA, Yamashita M, Kawaoka Y.

PLoS Pathog. 2010 Feb 26;6(2):e1000786. doi: 10.1371/journal.ppat.1000786.


T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.

Kiso M, Takahashi K, Sakai-Tagawa Y, Shinya K, Sakabe S, Le QM, Ozawa M, Furuta Y, Kawaoka Y.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):882-7. doi: 10.1073/pnas.0909603107. Epub 2009 Dec 22.


A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.

Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P; Vietnam H1N1 Investigation Team.

N Engl J Med. 2010 Jan 7;362(1):86-7. doi: 10.1056/NEJMc0910448. Epub 2009 Dec 9. No abstract available.


Ostrich involvement in the selection of H5N1 influenza virus possessing mammalian-type amino acids in the PB2 protein.

Shinya K, Makino A, Ozawa M, Kim JH, Sakai-Tagawa Y, Ito M, Le QM, Kawaoka Y.

J Virol. 2009 Dec;83(24):13015-8. doi: 10.1128/JVI.01714-09. Epub 2009 Sep 30.


Selection of H5N1 influenza virus PB2 during replication in humans.

Le QM, Sakai-Tagawa Y, Ozawa M, Ito M, Kawaoka Y.

J Virol. 2009 May;83(10):5278-81. doi: 10.1128/JVI.00063-09. Epub 2009 Mar 4.


Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells.

Kim SH, Oh SM, Song JH, Cho D, Le QM, Lee SH, Cho WJ, Kim TS.

Bioorg Med Chem. 2008 Feb 1;16(3):1125-32. Epub 2007 Oct 30.


Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice.

Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, Lien PS, Le QM, Kawaoka Y.

PLoS Pathog. 2007 Oct 5;3(10):1374-9.


Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA-topoisomerase I complex.

Van HT, Le QM, Lee KY, Lee ES, Kwon Y, Kim TS, Le TN, Lee SH, Cho WJ.

Bioorg Med Chem Lett. 2007 Nov 1;17(21):5763-7. Epub 2007 Aug 29.


Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.

Cho WJ, Le QM, My Van HT, Youl Lee K, Kang BY, Lee ES, Lee SK, Kwon Y.

Bioorg Med Chem Lett. 2007 Jul 1;17(13):3531-4. Epub 2007 Apr 25.


Avian flu: isolation of drug-resistant H5N1 virus.

Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y.

Nature. 2005 Oct 20;437(7062):1108. Erratum in: Nature. 2005 Dec 8;438(7069):754.


Elimination of dengue by community programs using Mesocyclops(Copepoda) against Aedes aegypti in central Vietnam.

Vu SN, Nguyen TY, Tran VP, Truong UN, Le QM, Le VL, Le TN, Bektas A, Briscombe A, Aaskov JG, Ryan PA, Kay BH.

Am J Trop Med Hyg. 2005 Jan;72(1):67-73.


Lack of SARS transmission among public hospital workers, Vietnam.

Le DH, Bloom SA, Nguyen QH, Maloney SA, Le QM, Leitmeyer KC, Bach HA, Reynolds MG, Montgomery JM, Comer JA, Horby PW, Plant AJ.

Emerg Infect Dis. 2004 Feb;10(2):265-8.

Supplemental Content

Loading ...
Support Center